Reserpine and Breast Cancer in a Retirement Community
- 26 June 1975
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 292 (26) , 1366-1371
- https://doi.org/10.1056/nejm197506262922603
Abstract
In an attempt to confirm three reports suggesting a causal link between rauwolfia antihypertensive drugs and female breast carcinoma, all cases of such cancer appearing among the residents of an affluent retirement community were compared with controls chosen from a roster of all women in the same community. Most residents use a single care facility, and patterns of hypertension diagnosis, rauwolfia and other drug use, and medical-care-system patronage were abstracted from medical records. The prevalence of recorded rauwolfia use among the controls was 20 per cent, and that of other drug use was correspondingly high. The risk ratio for rauwolfia use was estimated to be 1.2 (95 per cent confidence interval, 0.7 to 2.2). Risk ratios between 1.0 and 2.0 were also found for other drug use and for measures of care-system patronage. These results do not support the hypothesis that reserpine causes breast cancer. (N Engl J Med 292:1366–1371, 1975)Keywords
This publication has 11 references indexed in Scilit:
- ESSENTIAL HYPERTENSION AND BREAST CANCERThe Lancet, 1975
- BREAST CANCER AND HYPERTENSIONThe Lancet, 1974
- CARDIOVASCULAR DISEASESThe Lancet, 1974
- RESERPINE USE IN RELATION TO BREAST CANCERThe Lancet, 1974
- RETROSPECTIVE STUDY OF THE ASSOCIATION BETWEEN USE OF RAUWOLFIA DERIVATIVES AND BREAST CANCER IN ENGLISH WOMENThe Lancet, 1974
- Etiology of Human Breast Cancer: A Review2JNCI Journal of the National Cancer Institute, 1973
- Current status of hypertension control in an industrial populationJAMA, 1972
- Hypertension—A community problemThe American Journal of Medicine, 1972
- The epidemiology of breast cancer; Review and prospectsInternational Journal of Cancer, 1969
- The Prognosis of Essential Hypertension Treated ConservativelyCirculation, 1961